Abstract
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC; OMIM 248250) is a rare autosomal recessive kidney disease caused by mutations in the CLDN16 or CLDN19 genes encoding the proteins claudin-16 and claudin-19, respectively. These are involved in paracellular magnesium and calcium transport in the thick ascending limb of Henle’s loop and account for most of the magnesium reabsorption in the tubules. FHHNC is characterized by hypomagnesaemia, hypercalciuria, and nephrocalcinosis, and progresses to kidney failure, requiring dialysis and kidney transplantation mainly during the second to third decades of life. Patients carrying CLDN19 mutations frequently exhibit associated congenital ocular defects leading to variable visual impairment. Despite this severe clinical course, phenotype variability even among siblings has been described in this disease, suggesting unidentified epigenetic mechanisms or other genetic or environmental modifiers. Currently, there is no specific therapy for FHHNC. Supportive treatment with high fluid intake and dietary restrictions, as well as magnesium salts, thiazides, and citrate, are commonly used in an attempt to retard the progression of kidney failure. A kidney transplant remains the only curative option for kidney failure in these patients. In this review, we summarize the current knowledge about FHHNC and discuss the remaining open questions about this disorder.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
References
Praga M, Vara J, González-Parra E, Andrés A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419–1425. https://doi.org/10.1038/ki.1995.199
Claverie-Martin F (2015) Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics. Clin Kidney J 8:656–664. https://doi.org/10.1093/ckj/sfv081
Michelis MF, Drash AL, Linarelli LG, De Rubertis FR, Davis BB (1972) Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis. Metabolism 21:905–920. https://doi.org/10.1016/0026-0495(72)90025-X
Manz F, Schärer K, Janka P, Lombeck J (1978) Renal magnesium wasting, incomplete tubular acidosis, hypercalciuria and nephrocalcinosis in siblings. Eur J Pediatr 128:67–79. https://doi.org/10.1007/BF00477550
Haisch L, Almeida JR, Abreu Da Silva PR, Schlingmann KP, Konrad M (2011) The role of tight junctions in paracellular ion transport in the renal tubule: lessons learned from a rare inherited tubular disorder. Am J Kidney Dis 57:320–330. https://doi.org/10.1053/j.ajkd.2010.08.038
Rodriguez-Soriano J, Vallo A, García-Fuentes M (1987) Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol 1:465–472. https://doi.org/10.1007/BF00849255
Konrad M, Hou J, Weber S, Dötsch J, Kari JA, Seeman T, Kuwertz-Bröking E, Peco-Antic A, Tasic V, Dittrich K, Alshaya HO, von Vigier RO, Gallati S, Goodenough DA, Schaller A (2008) CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 19:171–181. https://doi.org/10.1681/ASN.2007060709
Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285:103–106. https://doi.org/10.1126/science.285.5424.103
Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, Lesslauer A, Vitzthum H, Suzuki Y, Luk JM, Becker C, Schlingmann KP, Schmid M, Rodriguez-Soriano J, Ariceta G, Cano F, Enriquez R, Juppner H, Bakkaloglu SA, Hediger MA, Gallati S, Neuhauss SC, Nurnberg P, Weber S (2006) Mutations in the Tight-junction gene Claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79:949–957
Hou J, Paul DL, Goodenough DA (2005) Paracellin-1 and the modulation of ion selectivity of tight junctions. J Cell Sci 118:5109–5118. https://doi.org/10.1242/jcs.02631
Hou J, Renigunta A, Konrad M, Gomes AS, Schneeberger EE, Paul DL, Waldegger S, Goodenough DA (2008) Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 118:619–628. https://doi.org/10.1172/JCI33970
Meier W, Blumberg A, Imahorn W, De Luca F, Wildberger H, Oetliker O (1979) Idiopathic hypercalciuria with bilateral macular coloboma: a new variant of oculo-renal syndrome. Helv Paediatr Acta 34:257–269
Nicholson JC, Jones CL, Powell HR, Walker RG, McCredie DA (1995) Familial hypomagnesaemia-hypercalciuria leading to end-stage renal failure. Pediatr Nephrol 9:74–76. https://doi.org/10.1007/BF00858976
Godron A, Harambat J, Boccio V, Mensire A, May A, Rigothier C, Couzi L, Barrou B, Godin M, Chauveau D, Faguer S, Vallet M, Cochat P, Eckart P, Guest G, Guigonis V, Houillier P, Blanchard A, Jeunemaitre X, Vargas-Poussou R (2012) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. J Am Soc Nephrol 7:801–809. https://doi.org/10.2215/CJN.12841211
Sikora P, Zaniew M, Haisch L, Pulcer B, Szczepańska M, Moczulska A, Rogowska-Kalisz A, Bieniaś B, Tkaczyk M, Ostalska-Nowicka D, Zachwieja K, Hyla-Klekot L, Schlingmann KP, Konrad M (2015) Retrospective cohort study of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations. Nephrol Dial Transplant 30:636–644. https://doi.org/10.1093/ndt/gfu374
Weber S, Schneider L, Peters M, Misselwitz J, Rönnefarth G, Böswald M, Bonzel KE, Seeman T, Suláková T, Kuwertz-Bröking E, Gregoric A, Palcoux JB, Tasic V, Manz F, Schärer K, Seyberth HW, Konrad M (2001) Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 12:1872–1881
Claverie-Martín F, García-Nieto V, Loris C, Ariceta G, Nadal I, Espinosa L, Fernández-Maseda Á, Antón-Gamero M, Avila A, Madrid Á, González-Acosta H, Córdoba-Lanus E, Santos F, Gil-Calvo M, Espino M, García-Martinez E, Sanchez A, Muley R, RenalTube Group (2013) Claudin-19 mutations and clinical phenotype in spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One 8:e53151. https://doi.org/10.1371/journal.pone.0053151
Benigno V, Canonica CS, Bettinelli A, von Vigier RO, Truttmann AC, Bianchetti MG (2000) Hypomagnesaemia – hypercalciuria – nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant 15:605–610
Yamaguti PM, Dos Santos PAC, Leal BS, Santana VB, Mazzeu JF, Acevedo AC, Neves Fde A (2015) Identification of the first large deletion in the CLDN16 gene in a patient with FHHNC and late-onset of chronic kidney disease: Case report. BMC Nephrol 16:92. https://doi.org/10.1186/s12882-015-0079-4
Quamme GA (1993) Magnesium homeostasis and renal magnesium handling. Miner Electrolyte Metab 19:218–225
Ariceta G (2013) Magnesium and infant health. In: Ross Watson R, Grimble G, Preedy VR, Zibadi S (eds) Nutrition in Infancy, 1st edn. Humana Press, New York, pp 417–428
Tang NLS, Cran YK, Hui E, Woo J (2000) Application of urine magnesium/creatinine ratio as an indicator for insufficient magnesium intake. Clin Biochem 33:675–678. https://doi.org/10.1016/S0009-9120(00)00173-9
Viering DHHM, de Baaij JHF, Walsh SB, Kleta R, Bockenhauer D (2017) Genetic causes of hypomagnesemia, a clinical overview. Pediatr Nephrol 32:1123–1135. https://doi.org/10.1007/s00467-016-3416-3
Curry JN, Yu ASL (2018) Magnesium handling in the kidney. Adv Chronic Kidney Dis 25:236–243. https://doi.org/10.1053/j.ackd.2018.01.003
de Baaij JHF, Hoenderop JGJ, Bindels RJM (2015) Magnesium in man: implications for health and disease. Physiol Rev 95:1–46. https://doi.org/10.1152/physrev.00012.2014
Di Stefano A, Roinel N, de Rouffignac C, Wittner M (1993) Transepithelial Ca2+ and Mg2+ transport in the cortical thick ascending limb of henle’s loop of the mouse is a voltage-dependent process. Ren Physiol Biochem 16:157–166. https://doi.org/10.1159/000173762
Hou J, Goodenough DA (2010) Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens 19:483–488. https://doi.org/10.1038/nature13314.A
Mount DB (2014) Thick ascending limb of the loop of henle. J Am Soc Nephrol 9:1974–1986. https://doi.org/10.2215/CJN.04480413
Günzel D, Fromm M (2012) Claudins and other tight junction proteins. Compr Physiol 2:1819–1852. https://doi.org/10.1002/cphy.c110045
Gong Y, Renigunta V, Himmerkus N, Zhang J, Renigunta A, Bleich M, Hou J (2012) Claudin-14 regulates renal Ca++ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J 31:1999–2012. https://doi.org/10.1038/emboj.2012.49
Bardet C, Courson F, Wu Y, Khaddam M, Salmon B, Ribes S, Thumfart J, Yamaguti PM, Rochefort GY, Figueres ML, Breiderhoff T, Garcia-Castaño A, Vallée B, Le Denmat D, Baroukh B, Guilbert T, Schmitt A, Massé JM, Bazin D, Lorenz G, Morawietz M, Hou J, Carvalho-Lobato P, Manzanares MC, Fricain JC, Talmud D, Demontis R, Neves F, Zenaty D, Berdal A, Kiesow A, Petzold M, Menashi S, Linglart A, Acevedo AC, Vargas-Poussou R, Müller D, Houillier P, Chaussain C (2016) Claudin-16 deficiency impairs tight junction function in ameloblasts, leading to abnormal enamel formation. J Bone Miner Res 31:498–513. https://doi.org/10.1002/jbmr.2726
Yamaguti PM, de AR NF, Hotton D, Bardet C, de La Dure-Molla M, Castro LC, Scher MD, Barbosa ME, Ditsch C, Fricain JC, de La Faille R, Figueres ML, Vargas-Poussou R, Houillier P, Chaussain C, Babajko S, Berdal A, Acevedo AC (2017) Amelogenesis imperfecta in familial hypomagnesaemia and hypercalciuria with nephrocalcinosis caused by CLDN19 gene mutations. J Med Genet 54:26–37. https://doi.org/10.1136/jmedgenet-2016-103956
Miyamoto T, Morita K, Takemoto D, Takeuchi K, Kitano Y, Miyakawa T, Nakayama K, Okamura Y, Sasaki H, Miyachi Y, Furuse M, Tsukita S (2005) Tight junctions in Schwann cells of peripheral myelinated axons: a lesson from claudin-19-deficient mice. J Cell Biol 169:527–538. https://doi.org/10.1083/jcb.200501154
Kriegs JO, Homann V, Kinne-Saffran E, Kinne RKH (2007) Identification and subcellular localization of paracellin-1 (claudin-16) in human salivary glands. Histochem Cell Biol 128:45–53. https://doi.org/10.1007/s00418-007-0291-9
Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN (2017) The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 136:665–677. https://doi.org/10.1007/s00439-017-1779-6
Prot-Bertoye C, Houillier P (2020) Claudins in renal physiology and pathology. Genes (Basel) 11:290. https://doi.org/10.3390/genes11030290
García-Castaño A, Perdomo-Ramirez A, Vall-Palomar M, Ramos-Trujillo E, Madariaga L, Ariceta G, Claverie-Martin F (2020) Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Mol Genet Genomic Med 8:e1475. https://doi.org/10.1002/mgg3.1475
Müller D, Kausalya PJ, Claverie-Martin F, Meij IC, Eggert P, Garcia-Nieto V, Hunziker W (2003) A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 73:1293–1301. https://doi.org/10.1086/380418
Kausalya PJ, Amasheh S, Günzel D, Wurps H, Müller D, Fromm M, Hunziker W (2006) Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16. J Clin Invest 116:878–891. https://doi.org/10.1172/JCI26323
Vianna JGP, Simor TG, Senna P, De Bortoli MR, Costalonga EF, Seguro AC, Luchi WM (2019) Atypical presentation of familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a patient with a new claudin-16 gene mutation. Clin Nephrol Case Stud 7:27–34. https://doi.org/10.5414/CNCS109595
Kutluturk F, Temel B, Uslu B, Aral F, Azezli A, Orhan Y, Konrad M, Ozbey N (2006) An unusual patient with hypercalciuria, recurrent nephrolithiasis, hypomagnesemia and G227R mutation of paracellin-1: an unusual patient with hypercalciuria and hypomagnesemia unresponsive to thiazide diuretics. Horm Res 66:175–181. https://doi.org/10.1159/000094253
Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, Demontis R, Fournier A, Paillard M, Houillier P (2001) Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59:2206–2215. https://doi.org/10.1046/j.1523-1755.2001.0590062206.x
Wang SB, Xu T, Peng S, Singh D, Ghiassi-Nejad M, Adelman RA, Rizzolo LJ (2019) Disease-associated mutations of claudin-19 disrupt retinal neurogenesis and visual function. Commun Biol 2:113. https://doi.org/10.1038/s42003-019-0355-0
Konrad M, Schlingmann KP (2014) Inherited disorders of renal hypomagnesaemia. Nephrol Dial Transplant 29:iv63–iv71. https://doi.org/10.1093/ndt/gfu198
Naeem M, Hussain S, Akhtar N (2011) Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease. Am J Nephrol 34:241–248. https://doi.org/10.1159/000330854
Sikora P, Zajączkowska M, Raganowicz T, Borzęcka H, Gregosiewicz A, Konrad M (2013) Bilateral slipped capital femoral epiphysis in a male adolescent with familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), chronic renal failure, and severe hyperparathyroidism. Eur J Pediatr 172:1551–1555. https://doi.org/10.1007/s00431-013-1979-6
Cimbek EA, Sen Y, Yuca SA, Peru H (2015) Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Pediatr Endocrinol Metab 28:713–716. https://doi.org/10.1515/jpem-2013-0254
Rim PC, Keith MP (2011) Chondrocalcinosis and hypomagnesemia in a 26-year-old woman. J Clin Rheumatol 17:334–335. https://doi.org/10.1097/rhu.0b013e31822c55df
Richette P, Ayoub G, Bardin T, Bouvet S, Orcel P, Badran AM (2005) Hypomagnesemia and chondrocalcinosis in short bowel syndrome. J Rheumatol 32:2434–2436
Faguer S, Chauveau D, Cintas P, Tack I, Cointault O, Rostaing L, Vargas-Poussou R, Ribes D (2011) Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations. J Am Soc Nephrol 6:355–360. https://doi.org/10.2215/CJN.02870310
Seeley HH, Loomba-Albrecht LA, Nagel M, Butani L, Bremer AA (2012) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis in three siblings having the same genetic lesion but different clinical presentations. World J Pediatr 8:177–180. https://doi.org/10.1007/s12519-011-0295-3
Arteaga ME, Hunziker W, Teo ASM, Hillmer AM, Mutchinick OM (2015) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: variable phenotypic expression in three affected sisters from Mexican ancestry. Ren Fail 37:180–183. https://doi.org/10.3109/0886022X.2014.977141
Kuwertz-Bröking E, Frund S, Bulla M, Kleta R, August C, Kisters K (2001) Familial hypomagnesemia-hypercalciuria in 2 siblings. Clin Nephrol 56:155–161
Deeb A, Abood SA, Simon J, Dastoor H, Pearce SH, Sayer JA (2013) A novel CLDN16 mutation in a large family with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. BMC Res Notes 6:1–7. https://doi.org/10.1186/1756-0500-6-527
Loris Pablo C, Martín de Vicente C, Abio Albero S, Justa Roldán M, Ferrer Novella C (2004) Hipomagnesemia familiar con hipercalciuria y nefrocalcinosis y asociación con alteraciones oculares. An Pediatr 61:502–508. https://doi.org/10.1157/13069183
Ariceta G, Aguirre M (2011) Tubulopatías en la infancia que progresan hacia la enfermedad renal crónica. NefroPlus 4:11–18. https://doi.org/10.3265/NefroPlus.pre2011.Feb.10852
Claverie-Martín F, Vargas-Poussou R, Müller D, García-Nieto V (2014) Clinical utility gene card for: familial hypomagnesemia with hypercalciuria and nephrocalcinosis with/without severe ocular involvement. Eur J Hum Genet 23:e1–e4. https://doi.org/10.1038/ejhg.2014.176
Agus ZS (2016) Mechanisms and causes of hypomagnesemia. Curr Opin Nephrol Hypertens 25:301–307. https://doi.org/10.1097/MNH.0000000000000238
Blanchard A, Bockenhauer D, Bolignano D, Calò LA, Cosyns E, Devuyst O, Ellison DH, Karet Frankl FE, Knoers NV, Konrad M, Lin SH, Vargas-Poussou R (2017) Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 91:24–33. https://doi.org/10.1016/j.kint.2016.09.046
Madariaga L, García-Castaño A, Ariceta G, Martínez-Salazar R, Aguayo A, Castaño L, Spanish group for the study of HNF1B mutations (2018) Variable phenotype in HNF1B mutations: extrarenal manifestations distinguish affected individuals from the population with congenital anomalies of the kidney and urinary tract. Clin Kidney J 12:373–379. https://doi.org/10.1093/ckj/sfy102
Rodríguez Soriano J (2002) Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 13:2160–2170. https://doi.org/10.1097/01.ASN.0000023430.92674.E5
Ariceta G, Vallo A, Rodriguez-Soriano J (2004) Acidosis increases magnesiuria in children with distal renal tubular acidosis. Pediatr Nephrol 19:1367–1370. https://doi.org/10.1007/s00467-004-1609-7
Zimmermann B, Plank C, Konrad M, Stöhr W, Gravou-Apostolatou C, Rascher W, Dötsch J (2006) Hydrochlorothiazide in CLDN16 mutation. Nephrol Dial Transplant 21:2127–2132. https://doi.org/10.1093/ndt/gfl144
Wolf MTF, Dötsch J, Konrad M, Böswald M, Rascher W (2002) Follow-up of five patients with FHHNC due to mutations in the Paracellin-1 gene. Pediatr Nephrol 17:602–608. https://doi.org/10.1007/s00467-002-0884-4
McCarthy JT, Torres VE, Romero JC, Wochos DN, Velosa JA (1982) Acute intrinsic renal failure induced by indomethacin: role of prostaglandin synthetase inhibition. Mayo Clin Proc 57:289–296
Peco-Antić A, Konrad M, Miloševski-Lomić G, Dimitrijević N (2010) Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: the first four patients in Serbia. Srp Arh Celok Lek 138:351–355. https://doi.org/10.2298/SARH1006351P
Dickson FJ, Sayer JA (2020) Nephrocalcinosis: a review of monogenic causes and insights they provide into this heterogeneous condition. Int J Mol Sci 21:369. https://doi.org/10.3390/ijms21010369
Okada K, Ishikawa N, Fujimori K, Goryo M, Ikeda M, Sasaki J, Watanabe D, Takasuga A, Hirano T, Sugimoto Y (2005) Abnormal development of nephrons in Claudin-16- defective Japanese Black cattle. J Vet Med Sci 67:171–178. https://doi.org/10.1292/jvms.67.171
Marunaka K, Fujii N, Kimura T, Furuta T, Hasegawa H, Matsunaga T, Endo S, Ikari A (2019) Rescue of tight junctional localization of a claudin-16 mutant D97S by antimalarial medicine primaquine in Madin-Darby canine kidney cells. Sci Rep 9:9647. https://doi.org/10.1038/s41598-019-46250-4
Müller D, Kausalya PJ, Bockenhauer D, Thumfart J, Meij IC, Dillon MJ, van't Hoff W, Hunziker W (2006) Unusual clinical presentation and possible rescue of a novel claudin-16 mutation. J Clin Endocrinol Metab 91:3076–3079. https://doi.org/10.1210/jc.2006-0200
Acknowledgements
We would like to acknowledge the FHHNC patient advocacy group Hipofam (Asociación para la Información y la Investigación de la Hipomagnesemia Familiar) (http://hipofam.org) for their valuable support and contribution to our research activity.
Funding
This work was funded by grants from the Instituto de Salud Carlos III, Fondo de Investigación Sanitaria (PI14/01107 and PI18/01107), the Department of Health of the Basque Government (2017111014), and the patient advocacy group Hipofam (Asociación para la Información y la Investigación de la Hipomagnesemia Familiar).
Author information
Authors and Affiliations
Contributions
All authors have written and reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Answers
1. d; 2. b; 3. d; 4. a; 5. d
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vall-Palomar, M., Madariaga, L. & Ariceta, G. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr Nephrol 36, 3045–3055 (2021). https://doi.org/10.1007/s00467-021-04968-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-021-04968-2